Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Parkinsons Disease Equipment Supplied In Europe
31 equipment items found
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Parkinson’s disease is a neurodegenerative disorder that affects more than 6 million people worldwide. In most cases, the exact cause of Parkinson’s disease is unknown; however, mutations in GBA1, the gene that encodes the beta-glucocerebrosidase (GCase) enzyme, have been tied to the disease. These ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1601 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1602 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The drug candidate ABBV-0805 is a monoclonal antibody that selectively binds and eliminates oligomers and protofibrils of alpha-synuclein. The goal is to develop a disease modifying treatment that stops or slows down disease ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
We are developing mGlu4 PAM as a novel orally available treatment for Parkinson's disease. We are currently optimizing multiple chemical series of highly selective mGlu4 PAMs with compounds in early lead ...
Manufactured by:Kaneka Eurogentec S.A. based inSeraing, BELGIUM
α-Synuclein is a major component of Lewy bodies in the affected neurons in Parkinson's disease. This protein has a mass of 14.5 kDa (140 amino acids long) and consists of a conserved degenerative amino-terminal domain and an acidic carboxyl-terminal with higher sequence divergence. α-Synuclein is predominantly expressed in brain, specifically in ...
Manufactured by:Gerresheimer AG based inDüsseldorf, GERMANY
This belt-worn on-body drug delivery device for small-molecule drugs has been developed for our pharma partner EVER Pharma. The wearable device is used by Parkinson's disease patients for the administration of apomorphine to treat this long-term degenerative disorder of the central nervous system. This device is customizable to be used with suitable other drugs ...
Manufactured by:LTS Lohmann Therapie-Systeme AG based inAndernach, GERMANY
The TTS innovations accommodate individual market positioning and lifecycle management of established products. They are well-suited for patients with special needs, including those with Parkinson’s disease, and are particularly beneficial for children, older adults, and patients with complex care requirements due to easier application and reduced dosage ...
Manufactured by:Manus Neurodynamica based inEdinburgh, UNITED KINGDOM
Motion features are translated into biomarkers to provide objective information about movement abnormalities which support diagnosis and monitoring of Parkinson's disease and other impairments. Full audit trail of results. Full monitoring of changes over time. Patented and CE marked as a medical device. Manufacturing setup with QMS according to all relevant ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Neuroscience is a heterogeneous field, requiring integrated analysis of multiple cell types, tissues and organs using diverse techniques. Prevention and effective treatment of neurological disorders like Alzheimer's and Parkinson's diseases has been a major medical challenge. ...
Manufactured by:betaSENSE based in, GERMANY
The advancement of the iRS technology from betaSENSE represents a significant innovation in the field of Parkinson's disease diagnostics. This technology addresses the critical unmet medical needs in accurately diagnosing Parkinson's and distinguishing between idiopathic and atypical cases. While there have been notable improvements in ...
Manufactured by:betaSENSE based in, GERMANY
This approach allows differentiation of protein secondary structures by their unique infrared absorption characteristics, aiding in early detection of diseases like Alzheimer's and Parkinson's. The technology facilitates early intervention by identifying amyloid-beta deposits linked to Alzheimer's well before symptomatic onset, using specific antibodies to study ...
by:Pureims B.V. based inRoden, NETHERLANDS
Levodopa Cyclops™ is a levodopa dry powder inhaler for the fast and reliable relief of OFF episodes in Parkinson’s disease. As such, Levodopa Cyclops™ answers a major unmet medical need. Levodopa is the cornerstone in the treatment of Parkinson’s disease for well over 50 years. It is the most effective, ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
Dipraglurant is a novel orally available highly selective metabotropic glutamate receptor subtype 5 negative allosteric modulator (mGlu5 NAM) which has completed Phase 1 and demonstrated efficacy in a Phase 2a proof of concept study for the treatment of levodopa-induced dyskinesia associated with Parkinson’s disease (PD-LID). This is a ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
mGlu2 NAM for the treatment of mild neurocognitive disorders, or mNCD. We are developing mGlu2 NAM as a novel orally available treatment for mNCD associated with Alzheimer’s disease, Parkinson’s disease and depressive disorders. The program is in clinical candidate selection phase and we expect to enter IND enabling studies early in ...
Manufactured by:Dobons Technology S.L. based inSanta Cruz de Tenerife, SPAIN
The laboratory for Electromedical Applications designs and builds at present a sort of instruments and systems derived from a 20 year old actitivity in the fields of ophtalmology (automated perimetry), physiology and, more recently, neurosurgery. ...
Manufactured by:Axinesis based inWavre, BELGIUM
Optimizing neuroplasticity and functional recovery with bimanual therapy supported by therapeutic gamification. REAtouch® is an interactive device for bimanual intensive therapy with a portfolio of therapeutic games suited for patients of all ...
Manufactured by:Axinesis based inWavre, BELGIUM
Deliver neurorehabilitation at home with REAtouch® Lite by Axinesis. The REAtouch® Lite portable rehabilitation device enables intensive functional neurorehabilitation in settings ranging from a rehabilitation centre to the patient’s ...
Manufactured by:ReGen Therapeutics Limited based inLondon, UNITED KINGDOM
The complex and the peptides within it are viewed as having potential utility in neurodegenerative illnesses such as Alzheimer’s disease, Parkinson’s Disease, Multiple Sclerosis and Amyotrophic Lateral ...
Manufactured by:Ncardia Services B.V. based inLeiden, NETHERLANDS
Cortical neurons play a vital role in many neurodegenerative diseases, including Alzheimer’s disease. Human iPSC-derived cortical neurons can be co-cultured with astrocytes and microglia to model neurodegenerative diseases. Our team can manufacture cortical neurons at scale from the iPSC line that best fits your project or work with off-the-shelf Ncyte Cortical Neurons to support your drug ...